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INTRODUCTION
Beckwitli and hiis associates(l) described the following features of a condition
subsequently called the exomplialos-macroglossia-gigantism (E IG) syndrome:
macroglossia; omphalocoele; visceromegaly; somatic gigantism and neonatal hly-
poglycemia. Combs et al.(2) studied two clhildren with this syndrome and demon-
strated that lhyperinsulinism and polycytlhemia during infancy were also part of
the syndrome. The facial abnormality was emphasized by Irving(3). Wiedemann
and his co-workers(4,5) and Hooft et al.(6) suggested that the etiology of this syn-
drome was a nonprogressive ablnormality of the dienceplhalon.
Tlhree studies recently published(7-9) lhave summarized the information cur-
rently available in the literature andlhave highliglhted the variability of the
syndrome.
The current paper reports studies carried out in eiglht such clhildren, three of
wlhom lhad lhypoglycemia. The clhanging nature of their hypoglycemia is docu-
mented, and hypoglycemia in the E1\IG syndrome is discussed.
PATIENTS STUDIED
The h-istory and physical findings present at birth in the eight patients are
shown in Table 1. Two of the patients (L.P. and P.R.) were partially discussed
* The children discussed in this publication were studied in the Yale University Children's
General Clinical Research Center RR-00125-06.
t Professor of Pediatrics, University of Missouri-Kansas City Medical School. Children's Mercy
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eHYPOGLYCEMIA IN EXOMPHALOS-MACROGLOSSIA-GIGANTISM
in a previous publication(2). With the exception of D.J., who was one of non-
identical twins, all of the patients were born at term. Three had hypoglycemic
seizures. Six of the eight were above the 90th percentile for both height and
weiglht. In these six, the measurements of head circumference ranged from the
10th to the 80tlh percentile, thus, frequently giving the appearance of micro-
ceplhaly. All eiglht lhad macroglossia, seven lhad midfacial hlypoplasia, five had an
abnormal umbilictus, and four were plethoric. As noted in Table 1, otlher ab-
normalities were less constant.
One patient (T.C.) had a cousin with this syndrome. None of the others had
any additional family members known to have this condition.
One patient (S.F.) previously reported as having the ENIG syndrome(2) must
now be considered as lhaving idiopathic hypoglycemia, since she neither had
macroglossia nor an abnormal umbilicus. Therefore, this patient was not included
in the current publication.
AVith the exception of G.T. who was Negro, all of the patients were Caucasian
and none was retarded.
METHODS
All eiglht children were fasted for periods of 12-24 hr starting at 6 P.1NI. after
hiaving eaten a (liet considered normal for the child's age for the 3 previous days
(Table 2). Dturing the fast period they were allowed only water to drink. The
two children wlho demonstrated hyperinsulinism (D.J. and L.P.) were fasted on
several occasions.
Intravenous glucose-tolerance tests were carried out in four patients (Table 3).
These tests were cloine at 8-9 A.M. after 12 lhr of fasting and subsequent to at
least 3 days of a dliet considered to be normal for the clhild's age. One gram of
gltucose per kg body weighit in a 20% solution was administered in 3-5 min.
Venous blood samples were obtained prior to and at 15-min intervals after glu-
cose injection for the first hour and at hourly intervals for the next 5 hr.
Tlhirty micrograms of glucagon (Lilly Glucagon for injection) per kg body
weiglht was injected intravenously for the glucagon-tolerance test. Venous blood
samples were obtained at 15-min intervals for 1 lhr. This test was performed at
the completion of the gltucose-tolerance test in four patients. Glucagon was also
administeredl to all eiglht patients at the completion of the 12- to 24-hr fast.
Blood samples were evaluated for glucose, using the glucose oxidase metlh-
od(10); immunoreactive insulin (IRI), using a double-antibody radioimmuno-
assay method(ll); and growth hormone (HGH), using a similar radioimmuno-
assay(12).
RESULTS
The blood glucose and IRI levels during the 12- to 24-hr periods of fasting
are shown in Table 2. Two patients (D.J. and L.P.) had spontaneous lhypogly-
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cemia and fasting insulin levels above 40 [U/ml durinig thie first year of life. (Jli
our laboratory the average 12-lhr fasting control IRI value for seven chliilrell,
4-16 months of age, is 14.3 ± 2.3 ,U/ml.) Subsequently they lhad hypoglycemia
onily wlhen fasted and at that time neitlher of these chliilren lha(l elevated levels of
IRI. Hypoglycemia was noted in one otlher patienit (P.R.). Wlhen tested at 2
months of age he developed lhypoglycemia after 20 lhr of fasting; hlowever, IRI
was not elevated. The otlher five lhad no symptoms of hypoglycemia andl were
able to stustain a 24-lhr fast witlhout cleveloping low blood-glucose levels.
Glucose- and glucagon-tolerance tests are shown in Table 3. Low blood-
gltucose levels were present witlhin 3 hr after glucose administration in four of
the five tests. In the fiftlh test (G.T.) blood glucose levels never fell below 56 mg
per 100 ml. The previously noted insulin levels above 40 ,uU/ml in D.J. and L.P.
TABLE 2
BlOOD GLUCOSE AND SERUM INSULIN LEVFELS DURING 12- TO 24-HOUR PERIODS OF FASTING
IN PATIENTS WITH ENIG SYNDROIME
Agc
Pt. (moniths) Testa
3 BG
4 BG
IRI
D.J. 6 BC
11 BG
40 BG
IRI
3 BG
IRI
L.P. 12 BG
IRI
20 BG
32 BG
IRI
D.G. 92 BG
IRI
P.R. 2 BG
IRI
K.B. 140 BG
IRI
T.C. 26 BG
IRI
J.C. 14 BG
IRI
G.T. 3 BG
IRI
Hours
12 14 16 18 20 22 24
48 45 41 38 38 38
54
44
13
70
34
80
57
60
93
50
73
2
63
4
65
7
67
6
87
4
50
9
10 40 48 68 51
77 48 43 24+ 35
65 53 27+-
2 3 0
85
17
5
81 44 28
40
9
I0
87
0
46 45 35
74 79
3 2
63
2
69
2
47
2
38*
63
1
55
1
68
2
55
8
a BG blood glucose (mg/100
+ =- ketonuria.
ml); IRI = immunoreactive insulin (AU/ml); * = sciztires;
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are seen here again. Neitlher P.R. nor G.T. lhad elevated IRI levels. HGH concen-
trations were sliglhtly elevated in the three patients (four tests) in whom it was
measured (normal fasting HGH levels are 0-3 ng/ml(13)). However, in each case
there was a normal fall in HGH concentrations after glucose administration.
All four patients lhad significantly elevated blood-glucose levels after glucagon
administration.
DISCUSSION
Hypoglycemia and associated hyperinsulinism have been noted in the first
descriptions of the EMIG syndrome(l,2). Subsequently it has become evident that
this is not invariably seen in all such patients. It is Beckwith's current impression
that only one third to one half of infants with this syndrome will have neonatal
hypoglycemia(7). Including the current study, approximately 59 such patients
hlave been describedI by various authors(l,3,4,6-9,14-18). Since many of these pa-
tients lhave not had blood glucose measured, and since in those patients in wlhom
this lhas been done, the measurement has been carried out at various ages, it is
very (lifficult to give an accurate percentage for the occurrence of hypoglycemia
in this syndrome. Nevertlheless, low blood-glucose levels have been documentedt
in 10 patients(l,6,9,14,16,18). However, the variability of this finding is seen in
the additioinal documenitation of normal blood-glucose concentrations in 15 chil-
dren with this syndrome(4,6-9).
TABLE 3
Bloor, GLUCOSE, SERUM INLSULIN, AND GROWt'TH HORNIONL AFTIE1.R GLUCOSE AND GLUCAGON
ADmINISTRATION IN PATIENTS WxITH ENIG SYNDROMFE
Initerval after INI
Age Interval after IN' glucose (mnil) glUcagon (mim1)
Pt. (monthls) 1eCst' 0 5 15 30 60 1290 180 240 300 360 15 30 45 60
BG 54 128 65 72 43 52 53 46 49 46 65 79 78
D.J. 4 IRI 44 88 75 44
HGH 5 1
BG 34 395 86 12 10 99 10 17 22 80 109 97 75
3 IRI 80 400 87
HG,H 4 2 2 3
L.P. BG 57 279 125 42 48 67 48 49 65 95 124 139 127
12 IRI 60 120 83 63
HGH 7 4 9 7
BG 63 419 358 211 99 50 34 15 21 33 90 120 110
P.R. 2 IRI 4 32 21 15
BG 76 374 255 182 65 56 76 8s0 93 120 97 73
G.T. 3 IRI 8 30 24 18 10
IIGH 4 3 3 0
HGH growth a BG =- loocd gltlcose (mg/100 ml); IRI = immunoreactive insulin (,uU/ml);
hormone (ng/ml).
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Only two other groups of workers have measured insulin in these chil-
dren(l,2,18) giving a total of five documented cases of hyperinsulinemia. To these
data must be added the significant number of such patients who have had hy-
perplasia of the Islets of Langerhans. Thirteen of the 22 patients who have come
to autopsy have had this finding(3,7,8,9,15) and althouglh insulin levels were not
measuredl, the possibility of hyperinsulinism is (listinct. Despite tlle few data, it
wouldI appear that hyperinsulinism is a significant factor in many of tllese
patients.
As has been noted above, not all of these patients have hypoglycemia. In adldi-
tion, it is likely that not all of these patients with hypoglycemia have hyperin-
sulinism. In our study one patient (P.R.) had significant hypoglycemia witlhotit
hlyperinsulinism at 7 weeks of age. The demonstration of low 10lood glucose in
these patients does not warrant the assumption that serum insulini levels ar-e
higlh if such measurements are not made.
In the two patients in this study with neonatal hyperinsulinemic hypoglycemia,
insulin levels were higlh (tirinig the first year of life. Subsequently, these patients
developed low blood glucose values only wlhen fasted for 12-24 hr. This sporadic
lhypoglycemia was not associated with elevatedl insulin levels and (lisappeared
spontaneously between 3 and 5 years of age.
Mfany of these large newborn infants with marked polycythemia developed
into mildlly microceplhalic, nonplethoric clhildlren witlhout the previously noted
somatic gigantism. Excess insulin has been shown to be associatedl with poly-
cythemia(19) and to act as an excellent stimulus for growth(20). Tlhtls, the possi-
bility exists that both the neonatal findings as well as the subsequent clhanges in
growtlh pattern can be explained oIn the basis of hyperinsulinism (lurinlg intra-
uterine, neonatal, and early childlhoodl development.
The responises to glucose administr-ation were variable (Talble 3) and tlherefore
difficult to explaiin. Tlhree of the four patients tested (D.J., L.P., and P.R.) de-
velopecl hypoglycemia during the gltucose-tolerance tests. Glucose utilization was
extremely rapid in D.J. Fifteen miniutes after the glucose injection lher blood-
glucose was only 65 mg per 100 ml. L.P., wlhose low blood glucose was first seen
1 hr after glucose administration, may lhave had a reactive or stimulative ratlher
than fasting hypoglycemia. P.R. had a blood glucose value of 34 mg per 100 ml
3 hr after glucose administration. Since this value was obtained after 15 hr of
fasting, and since this patient had a blood glucose value of 46 mg per 100 ml
after 14 hr of fasting on another occasion (Table 2) this patient's low blood glu-
cose most likely represents fasting hypoglycemia.
Since there was a significant increase in blood glucose in each patient given
glucagon (Table 3), it would appear that these patients have no abnormality in
glycogen synthesis and release.
Several investigators have suggested that the etiology of this condition is a non-
progressive dysfunction of the hypothalamus(4-6). Our findings do not yield di-
rect evidence to corroborate this thesis. However, in light of the work of
Cornblath et al.(21) showing that central nervous system lesions could alter the
blood glucose, free fatty acid, and insulin responses to an intravenous glucose
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load in macaque monkeys, the transient abnormality in the control of carbohy-
drate homeostasis whiclh occurs in these children may be indirect evidence of
central nervous system malfunction. This malfunction appears to involve hyper-
insulinism initially and subsequently involves otlher mechanisms which are, as
yet, poorly understood. It has been suggested that the central nervotis system
may play a role in the control of glucagon secretion(22). With this possibility in
Mind, the inability to demonstrate any serum glucagon in one patient with the
ENfG syndrome(18) may represent still another aspect of malfunction in central
nervous system control of carbohydrate lhomeostasis. The potential importance of
this syndrome as an aidI to the understanding of suclh central nervous system
fuLnction as well as carbohydrate homeostasis in hypoglycemic states certainly
warrants careful study of each of these hypoglycemic patients from birth until
that time when they can sustain a 94-hr fast without the development of low
blood glucose.
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